Атеротромбоз (Jul 2016)
EFFICACY AND SAFETY OF DIRECT ORAL ANTICOAGULANTS IN THE PREVENTION OF STROKE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION IN EVERYDAY CLINICAL PRACTICE: FACTS ABOUT RIVAROXABAN
Abstract
The article tells about the experience with rivaroxaban for the prevention of stroke and thromboembolism not involving the central nervous system vessels in patients with non-valvular atrial fibrillation in a number of clinical cases. The article demonstrates that rivaroxaban’s efficacy and safety in everyday medical practice, in general, meets the expectations resulting from the large controlled ROCKET-AF trial.
Keywords